Treatment patterns of elderly breast cancer patients at two Canadian cancer centres

European Journal of Surgical Oncology

Volumn 41, Issue 5, 2015, Pages 625-634

  Angarita, F A ^a   Chesney, T ^a   Elser, C ^b   Mulligan, A M ^c   McCready, D R ^a,d   Escallon, J ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Adjuvant therapy; Aged; Breast neoplasm; Neoadjuvant therapy; Treatment outcomes

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN;

AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GERIATRIC PATIENT; GROUPS BY AGE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TREATMENT INDICATION; VERY ELDERLY; AGE; BREAST NEOPLASMS; CANADA; CANCER STAGING; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CLINICAL TRIAL; LYMPH NODE DISSECTION; METABOLISM; MULTICENTER STUDY; PATHOLOGY; SEGMENTAL MASTECTOMY; TUMOR VOLUME; UTILIZATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CANADA; CANCER CARE FACILITIES; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; MASTECTOMY; MASTECTOMY, SEGMENTAL; NEOPLASM STAGING; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 84931474142     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.01.028     Document Type: Article

References (41)

1. Altekruse SF, Kosary CL, Krapcho M, et al. In: Anonymous, editor. SEER cancer statistics review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010.
2. National Cancer Institute (NCI). Surveillance, Epidemiology, and End Results (SEER) Program. URL: www.seer.cancer.gov/popdata. [accessed 30.10.14].
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
4. Hamaker ME, Schreurs WH, Uppelschoten JM, Smorenburg CH. Breast cancer in the elderly: retrospective study on diagnosis and treatment according to national guidelines. Breast J 2009;15:26-33.
5. Wyld L, Garg DK, Kumar ID, Brown H, Reed MW. Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines. Br J Cancer 2004;90:1486-91.
6. Gajdos C, Tartter PI, Bleiweiss IJ, Lopchinsky RA, Bernstein JL. The consequence of undertreating breast cancer in the elderly. J Am Coll Surg 2001;192:698-707.
7. Bouchardy C, Rapiti E, Fioretta G, et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003;21:3580-7.
8. Owusu C, Lash TL, Silliman RA. Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women. Breast Cancer Res Treat 2007;102:227-36.
9. Yood MU, Owusu C, Buist DS, et al. Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg 2008;206:66-75.
10. Collins LC, Botero ML, Schnitt SJ. Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases. Am J Clin Pathol 2005;123:16-20.
11. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN guidelines)®. Breast Cancer Version 3 2014. URL: http://www.nccn.org/professionals/physician-gls/pdf/breast.pdf. [accessed 30.10.14].
12. Biganzoli L, Wildiers H, Oakman C, et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 2012;13:e148-60.
13. Schonberg MA, Marcantonio ER, Li D, et al. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol 2010;28:2038-45.
14. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:727-37. W237-42.
15. Malmgren JA, Parikh J, Atwood MK, Kaplan HG. Improved prognosis of women aged 75 and older with mammography-detected breast Cancer. Radiology 2014;140209.
16. Weggelaar I, Aben KK, Warle MC, Strobbe LJ, van Spronsen DJ. Declined guideline adherence in older breast cancer patients: a population-based study in the Netherlands. Breast J 2011;17:239-45.
17. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000;92:550-6.
18. Rocco N, Rispoli C, Pagano G, et al. Undertreatment of breast cancer in the elderly. BMC Surg 2013;13(suppl. 2). S26-2482-13-S2-S26. Epub 2013 Oct 8.
19. Cutuli B, Lemanski C, Fourquet A, et al. Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience. Br J Cancer 2009;100:1048-54.
20. Lavelle K, Downing A, Thomas J, et al. Are lower rates of surgery amongst older women with breast cancer in the UK explained by co-morbidity? Br J Cancer 2012;107:1175-80.
21. Kaur P, Santillan AA, McGuire K, et al. The surgical treatment of breast cancer in the elderly: a single institution comparative review of 5235 patients with 1028 patients >/=70 years. Breast J 2012;18:428-35.
22. Joerger M, Thurlimann B, Savidan A, et al. Treatment of breast cancer in the elderly: a prospective, population-based Swiss study. J Geriatr Oncol 2013;4:39-47.
23. Kiderlen M, Bastiaannet E, Walsh PM, et al. Surgical treatment of early stage breast cancer in elderly: an international comparison. Breast Cancer Res Treat 2012;132:675-82.
24. van de Water W, Markopoulos C, van de Velde CJ, et al. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 2012;307:590-7.
25. van de Water W, Bastiaannet E, Dekkers OM, et al. Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg 2012;99:813-20.
26. Hancke K, Denkinger MD, Konig J, et al. Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Ann Oncol 2010;21:748-53.
27. Wildiers H, Kunkler I, Biganzoli L, et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007;8:1101-15.
28. Figueiredo MI, Cullen J, Hwang YT, Rowland JH, Mandelblatt JS. Breast cancer treatment in older women: does getting what you want improve your long-term body image and mental health? J Clin Oncol 2004;22:4002-9.
29. Vetter M, Huang DJ, Bosshard G, Guth U. Breast cancer in women 80 years of age and older: a comprehensive analysis of an underreported entity. Acta Oncol 2013;52:57-65.
30. Martelli G, Boracchi P, De Palo M, et al. A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg 2005;242:1-6. discussion 7-9.
31. International Breast Cancer Study GroupRudenstam CM, Zahrieh D, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol 2006;24:337-44.
32. Martelli G, Miceli R, Daidone MG, et al. Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol 2011;18:125-33.
33. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305:569-75.
34. Bouchardy C, Rapiti E, Blagojevic S, Vlastos AT, Vlastos G. Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol 2007;25(14):1858-69.
35. Fargeot P, Bonneterre J, Roche H, et al. Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial. J Clin Oncol 2004;22:4622-30.
36. Ibrahim NK, Buzdar AU, Asmar L, Theriault RL, Hortobagyi GN. Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up. Ann Oncol 2000;11:1597-601.
37. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer. Cochrane Database Syst Rev 2001;(1):CD000486.
38. Baum M, Budzar AU, Cuzick J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 2002;359:2131-9.
39. Laki F, Kirova YM, Savignoni A, et al. Management of operable invasive breast cancer in women over the age of 70: long-term results of a large-scale single-institution experience. Ann Surg Oncol 2010;17:1530-8.
40. Wyld L, Reed M. The role of surgery in the management of older women with breast cancer. Eur J Cancer 2007;43:2253-63.
41. Patnaik JL, Byers T, Diguiseppi C, Denberg TD, Dabelea D. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 2011;103:1101-11.